Metreon Bioproducts GmbH

METREON

Pharmaceutical and sanitary preparations, namely, cells and cell lines, namely, peripheral blood stem cells, skin cells (keratinocytes) and other cells which can be reproduced in vitro; genetically modified cells; autologous and allogenous cells, particularly for medical treatment comprising inserting genes into cells in order to express the foreign gene in the patient to provide treatment for cancer and a wide variety of other illnesses;Services of a medical or biochemical laboratory, namely, provision of cells and cell lines for medical treatment of patients, provision of transfected or otherwise genetically modified cells and cell lines; modification of cells and cell lines by implanting genes into the cell lines; production of human cells and cell lines which can be used for the treatment of patients;

METREON

pharmaceutical and sanitary preparations, in particular cells and cell lines like peripheral blood stem cells, skin cells (keratinocytes), and other cells which can be reproduced in vitro; genetically modified cells; autologous and allogenous cells, particularly for medical treatment of patients; services of a medical or biochemical laboratory, particularly provision of cells and cell lines for medical treatment of patients, provision of , !, I cell lines; productions of human cells and cell lines which can be used for the treatment of patients;Services of a medical or biochemical laboratory, namely provision of cells and cell lines for medical treatment of patients, provision of transfected or otherwise genetically modified cells and cell lines; modification of cells and cell lines by implanting genes into the cell lines; production of human cells and cell lines which can be used for the treatment of patients;